Isolation, identification and whole-genome analysis of an Achromobacter strain with a novel sulfamethazine resistance gene and sulfamethazine degradation gene cluster

Copyright © 2024 Elsevier Ltd. All rights reserved..

A sulfamethazine (SM2) degrading strain, Achromobacter mucicolens JD417, was isolated from sulfonamide-contaminated sludge using gradient acclimation. Optimal SM2 degradation conditions were pH 7, 36 °C, and 5 % inoculum, achieving a theoretical maximum degradation rate of 48 % at 50 ppm SM2. Cell growth followed the Haldane equation across different SM2 concentrations. Whole-genome sequencing of the strain revealed novel functional annotations, including a sulfonamide resistance gene (sul4) encoding dihydropteroate synthase, two flavin-dependent monooxygenase genes (sadA and sadB) crucial for SM2 degradation, and unique genomic islands related to metabolism, pathogenicity, and resistance. Comparative genomics analysis showed good collinearity and homology with other Achromobacter species exhibiting organics resistance or degradation capabilities. This study reveals the novel molecular resistance and degradation mechanisms and genetic evolution of an SM2-degrading strain, providing insights into the bioremediation of sulfonamide-contaminated environments.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:399

Enthalten in:

Bioresource technology - 399(2024) vom: 25. Apr., Seite 130598

Sprache:

Englisch

Beteiligte Personen:

Zeng, Luping [VerfasserIn]
Du, Hongwei [VerfasserIn]
Lin, Xianke [VerfasserIn]
Liao, Ruomei [VerfasserIn]
Man, Ying [VerfasserIn]
Fang, Huaiyang [VerfasserIn]
Yang, Yang [VerfasserIn]
Tao, Ran [VerfasserIn]

Links:

Volltext

Themen:

21240MF57M
48U51W007F
Achromobacter
Antibiotic resistance
Comparative genomics
Journal Article
Sulfamethazine
Sulfanilamide
Sulfonamides
Whole-genome sequencing

Anmerkungen:

Date Completed 12.04.2024

Date Revised 12.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.biortech.2024.130598

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369836235